An eQTL-based method identifies CTTN and ZMAT3 as pemetrexed susceptibility markers. - Wikidata - awgldk - TriplyDB

An eQTL-based method identifies CTTN and ZMAT3 as pemetrexed susceptibility markers.

An eQTL-based method identifies CTTN and ZMAT3 as pemetrexed susceptibility markers.

http://www.wikidata.org/entity/Q33398764

about

Cancer pharmacogenomics: strategies and challenges Protein quantitative trait loci identify novel candidates modulating cellular response to chemotherapy EPS8 inhibition increases cisplatin sensitivity in lung cancer cells.Reprogramming LCLs to iPSCs Results in Recovery of Donor-Specific Gene Expression Signature Relating human genetic variation to variation in drug responses.Utility of Lymphoblastoid Cell Lines for Induced Pluripotent Stem Cell Generation Genetic and epigenetic variants contributing to clofarabine cytotoxicity.Genome-wide association study of lymphoblast cell viability after clozapine exposure.Gene and MicroRNA Perturbations of Cellular Response to Pemetrexed Implicate Biological Networks and Enable Imputation of Response in Lung Adenocarcinoma.

P2860

Q24289309-FE0F1A5D-9B34-469A-B123-5F6C860F792C Q28541831-FF0FE1FB-FFEB-49FB-857F-99C1EDD70CFC Q35075274-5A6E185B-3401-433E-9000-A18EAD47D3EC Q35624163-B5ACDAE3-9631-4FE7-B4E5-E010F36FA40C Q36252524-DE52F6C6-5055-4F5B-B7D8-5D54EB5109F8 Q37023448-5188C2D4-DB8F-4A67-9EC1-730A26BBA53E Q37153800-5CAB90BB-9847-41D5-9A6E-A971D6BE4335 Q38967700-BBF9B107-A739-4134-9876-10E2EECCE3C0 Q48239512-E71EC25F-3431-43F4-B627-B58D110CE07B

P2860

An eQTL-based method identifies CTTN and ZMAT3 as pemetrexed susceptibility markers.

http://www.wikidata.org/entity/Q33398764

description

2011 nî lūn-bûn

@nan

2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

An eQTL-based method identifies CTTN and ZMAT3 as pemetrexed susceptibility markers.

@ast

An eQTL-based method identifies CTTN and ZMAT3 as pemetrexed susceptibility markers.

@en

type

label

An eQTL-based method identifies CTTN and ZMAT3 as pemetrexed susceptibility markers.

@ast

An eQTL-based method identifies CTTN and ZMAT3 as pemetrexed susceptibility markers.

@en

prefLabel

An eQTL-based method identifies CTTN and ZMAT3 as pemetrexed susceptibility markers.

@ast

An eQTL-based method identifies CTTN and ZMAT3 as pemetrexed susceptibility markers.

@en

P1433

Q33398764-FA0BB2F1-9716-4EA9-9B80-0B9691A50A58

P1476

Q33398764-14F2B9E4-BD75-4EE6-B158-13D14C0DA06C

P2093

Q33398764-0DEB8BF1-B126-428C-AED8-1AFD91E8C18E

Q33398764-3245F2A7-6CB4-47E9-B3A3-8054C46B117D

Q33398764-3A6361CB-5CE1-472F-8CDE-AB8FB3E59D76

Q33398764-7C022B36-B676-4AC5-B9D5-A948922BDE14

Q33398764-A52CB662-6CE2-46F2-A4E0-ACB02D019369

Q33398764-B69D053E-416D-47C2-B5D0-6520B11B501C

Q33398764-E56D0E15-7C74-499B-B7DA-C070BF93C68B

P2860

Q33398764-10A7ADA9-43B4-4B06-8750-C9490C31F303

Q33398764-1BF4BCE4-2178-4591-9602-AFCF655E761A

Q33398764-206FECF1-99C9-4D9E-8BCC-9122DFE5BD16

Q33398764-25DC9129-36DC-453D-98AC-54FB1DDFC723

Q33398764-3059FEDB-1BD3-484C-8D16-A9EB3ACFED33

Q33398764-379295D7-1F72-4EA5-A6F1-3A32387054EF

Q33398764-37BF6590-2894-4E6F-8FFD-F50BB9F151F8

Q33398764-4286CF8B-E75B-45C8-8DAC-917AE7C2D77B

Q33398764-42B12B64-5A9B-41A2-9320-883FF17295E8

Q33398764-45E5AB99-DDCF-4CB9-AF74-68283CA4E821

P304

Q33398764-D3B1957E-C08C-4233-A4DB-C297878E56DE

P31

Q33398764-F39B7753-EC40-4D43-A25D-B04A8EC7279A

P356

Q33398764-EFDC7C61-C8B1-4C6B-BC52-11E91B378946

P433

Q33398764-B9FFEA91-D3DE-4B2E-B966-C0F85DC4114F

P478

Q33398764-AA66A895-3A11-400F-965F-9A2CE61DCDF0

P50

Q33398764-9CABCAFE-65A4-4380-9BE8-FBED0FDFBC82

Q33398764-A4B5EE93-DF57-4FD3-B0C4-F1C094B856DE

Q33398764-F7A3DD26-AADA-4310-9D8E-046E250281BF

P577

Q33398764-EB6EEE43-EC42-4E9B-97B5-41AA056AFE58

P5875

Q33398764-1DAD36AD-3052-43B0-BF37-41F025DB25DC

P698

Q33398764-E42986DE-FEE2-4D99-9D8B-7E529FFA90C1

P932

Q33398764-281C880D-90AA-4B7C-A11C-247E88B9D6D9

P356

P1433

Human Molecular Genetics

P1476

An eQTL-based method identifies CTTN and ZMAT3 as pemetrexed susceptibility markers.

@en

P2093

Bridget E McIlwee

http://www.w3.org/2001/XMLSchema#string

M Eileen Dolan

http://www.w3.org/2001/XMLSchema#string

Shannon M Delaney

http://www.w3.org/2001/XMLSchema#string

Shiwei Duan

http://www.w3.org/2001/XMLSchema#string

Shuangli Mi

http://www.w3.org/2001/XMLSchema#string

Wasim K Bleibel

http://www.w3.org/2001/XMLSchema#string

Yujia Wen

http://www.w3.org/2001/XMLSchema#string

P2860

Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS

The p53 target protein Wig-1 binds hnRNP A2/B1 and RNA Helicase A via RNA

Chemotherapeutic drug susceptibility associated SNPs are enriched in expression quantitative trait loci

Haploview: analysis and visualization of LD and haplotype maps

A Cortactin-CD2-associated protein (CD2AP) complex provides a novel link between epidermal growth factor receptor endocytosis and the actin cytoskeleton

Roles of cortactin in tumor pathogenesis

Pharmacogenomic discovery using cell-based models

Genomic control for association studies

A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity.

Phase I trials of pemetrexed.

P304

1470-1480

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/HMG/DDR583

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

Eric R. Gamazon

P577

2011-12-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51881183

http://www.w3.org/2001/XMLSchema#string

P698

22171072

http://www.w3.org/2001/XMLSchema#string

P932

3298275

http://www.w3.org/2001/XMLSchema#string